C0282443||Review
C0309470||Methylprednisolone Acetate Intra-Articular Injection
C0376636||Management
C0409959||Osteoarthritis of the Knee
C0449445||approach
C0376636||management
C0409959||osteoarthritis (OA) of the knee
C1272883||injections
C1272883||injection
C0282443||review
C0442108||intra-articular
C0309470||methylprednisolone acetate (MPA) injections
C0376636||management
C0409959||OA knee
C0282443||review
C0936005||published guidelines
C0023866||literature
C0023866||literature
C0282443||review
C0442108||intra-articular
C0309470||MPA injection
C0030193||pain
C1535551||function
C0162298||stiffness
C1522577||follow-up periods
C0600901||methylprednisolone acetate
C0443077||corticosteroid products
C0021488||IA injections
C0409959||OA knee
C0443077||corticosteroid products
C0282443||review
C0877248||adverse events
C0600901||methylprednisolone acetate
C1457887||symptom
C0451615||relief
C0409959||OA knee
C0237401||individual
C0376636||management
C1272883||injections
C0282451||clinical guidelines
C0376636||management
C0409959||OA knee
C0237401||person
C1274016||clinical history
C0231170||disability
C0035648||risk factors